Currently, the share price for Concord Biotech Ltd. is delayed. Login to view live prices.
Concord Biotech Ltd.
-- ( -- %) 1D
- Prev. Close1,321.75
- Upper Circuit1,579.80
- Lower Circuit1,053.20
Analyst Recommendations For Concord Biotech Ltd.
As recommended by 4 analysts
Concord Biotech Ltd.'s Info & Management
Concord Biotech Is Engaged In Research And Development, Manufacturing, Marketing And Selling Of Pharmaceutical Products.(Source : 202303 Annual Report Page No:117)
- Vice President(Formulations),Head(Unit II)Manoj Kumar
- Chief Finance OfficerLalit Sethi
- Vice President(Sales & Marketing),Head(Plant)Devang Bhatt
- Company Secretary,Compliance Officer,Senior General Manager(Finance)Prakash Lalchand Sajnani
- General Manager(International Business Devpt,Formulations,Division.)Sundeep Bengani
FAQs on Concord Biotech Ltd.
What is the share price of Concord Biotech Ltd.?
Concord Biotech Ltd. share price is ₹1,316.50 as of December 8, 2023, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Concord Biotech Ltd.?
The 52-week high and low of Concord Biotech Ltd. is ₹1,396.95 and ₹901.00 respectively as of December 8, 2023, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Concord Biotech Ltd.?
The trailing twelve month (TTM) PB ratio of Concord Biotech Ltd. is 10.70 as of December 11, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Concord Biotech Ltd.?
The Upper Circuit of Concord Biotech Ltd. is ₹1,579.8. The Lower Circuit of Concord Biotech Ltd. is ₹1,053.2.
What is the ROE of Concord Biotech Ltd.?
Concord Biotech Ltd. reported an ROE of 18.61% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Concord Biotech Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Concord Biotech Ltd., Promoter held 44.1%, the FII held 7.3%, DII held 8.2% and the public held 40.4% of the total shares.
How to buy Concord Biotech Ltd. Share?
What is the fair value of Concord Biotech Ltd.?
The fair value of Concord Biotech Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.